Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Operating expenses:
Research and development	$ 55,322	$ 27,985	$ 105,972	$ 49,772
General and administrative	10,419	7,644	19,723	14,610
Total operating expenses	65,741	35,629	125,695	64,382
Loss from operations	(65,741)	(35,629)	(125,695)	(64,382)
Interest expense	(1,231)	(857)	(2,222)	(1,314)
Interest and other income, net	10,985	5,403	18,586	8,782
Net loss	(55,987)	(31,083)	(109,331)	(56,914)
Net unrealized loss on marketable securities	(182)	(272)	(531)	(288)
Comprehensive loss	$ (56,169)	$ (31,355)	$ (109,862)	$ (57,202)
Net loss per share, basic	$ (0.81)	$ (0.6)	$ (1.7)	$ (1.15)
Net loss per share, diluted	$ (0.81)	$ (0.6)	$ (1.7)	$ (1.15)
Weighted-average number of shares used in computing net loss per common share, basic	69,160,484	51,867,854	64,234,122	49,419,558
Weighted-average number of shares used in computing net loss per common share, diluted	69,160,484	51,867,854	64,234,122	49,419,558